{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:52:55Z","timestamp":1777445575697,"version":"3.51.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40263-018-0576-7","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:18:03Z","timestamp":1538036283000},"page":"951-961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Palliative Sedation for the Terminally Ill Patient"],"prefix":"10.1007","volume":"32","author":[{"given":"Ferdinando","family":"Garetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Cancelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Maltoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"576_CR1","unstructured":"Byock I. Palliative care and the right to die. In: The 2015 Quality of death index. Ranking palliative care across the world. The Economist Intelligence Unit. 2018. https:\/\/www.eiuperspectives.economist.com\/sites\/default\/files\/2015%20EIU%20Quality%20of%20Death%20Index%20Oct%2029%20FINAL.pdf . Accessed 19 May 2018."},{"key":"576_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmjspcare-2012-000431","volume":"3","author":"N Juth","year":"2013","unstructured":"Juth N, Lindblad A, Lyn\u00f6e N, Sj\u00f6strand M, Helgesson GM. Differences in deep continuous palliative sedation and euthanasia. BMJ Support Palliat Care. 2013;3:203\u20136.","journal-title":"BMJ Support Palliat Care."},{"key":"576_CR3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.23736\/S0375-9393.17.12091-2","volume":"83","author":"G Miccinesi","year":"2017","unstructured":"Miccinesi G, Caraceni A, Maltoni M. Palliative sedation: ethicalaspects. Minerva Anestesiol. 2017;83:1317\u201323.","journal-title":"Minerva Anestesiol."},{"key":"576_CR4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0269216309107024","volume":"23","author":"NI Cherny","year":"2009","unstructured":"Cherny NI, Radbruch L. Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23:581\u201393.","journal-title":"Palliat Med."},{"key":"576_CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/jpm.2013.0511","volume":"17","author":"E Schildmann","year":"2014","unstructured":"Schildmann E, Schildmann J. Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making. J Palliat Med. 2014;17:601\u201311.","journal-title":"J Palliat Med."},{"key":"576_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/CCO.0000000000000097","volume":"26","author":"M Maltoni","year":"2014","unstructured":"Maltoni M, Scarpi E, Nanni O. Palliative sedation for intolerable suffering. Curr Opin Oncol. 2014;26:389\u201394.","journal-title":"Curr Opin Oncol."},{"key":"576_CR7","first-page":"446","volume":"83","author":"P Cotogni","year":"2017","unstructured":"Cotogni P, Brazzi L. Palliative sedation: a feasible option to improve end-of-life care in seriously ill dying patients. Minerva Anestesiol. 2017;83:446\u20138.","journal-title":"Minerva Anestesiol."},{"key":"576_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/bmjspcare-2016-001159","volume":"7","author":"E Abarshi","year":"2017","unstructured":"Abarshi E, Rietjens J, Robijn L, Caraceni A, Payne S, Deliens L, et al. International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care. 2017;7:223\u20139.","journal-title":"BMJ Support Palliat Care."},{"key":"576_CR9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.2011.37.3795","volume":"30","author":"M Maltoni","year":"2012","unstructured":"Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, et al. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012;30:1378\u201383.","journal-title":"J Clin Oncol."},{"issue":"15","key":"576_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12904-016-0121-8","volume":"14","author":"S Schur","year":"2016","unstructured":"Schur S, Weixler D, Gabl C, Kreye G, Likar R, Masel EK, et al. AUPACS (Austrian Palliative Care Study) Group. Sedation at the end of life - a nation-wide study in palliative care units in Austria. BMC Palliat Care. 2016;14(15):50.","journal-title":"BMC Palliat Care."},{"key":"576_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1049909115572991","volume":"33","author":"D Azoulay","year":"2016","unstructured":"Azoulay D, Shahal-Gassner R, Yehezkel M, Eliyahu E, Weigert N, Ein-Mor E, et al. Palliative sedation at the end of life: patterns of use in an israeli hospice. Am J Hosp Palliat Care. 2016;33:369\u201373.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jpainsymman.2017.10.006","volume":"55","author":"J Hamano","year":"2018","unstructured":"Hamano J, Morita T, Ikenaga M, Abo H, Kizawa Y, Tunetou S. A nationwide survey about palliative sedation involving Japanese palliative care specialists: Intentions and key factors used to determine sedation as proportionally appropriate. J Pain Symptom Manage. 2018;55:785\u201391.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-13-17","volume":"13","author":"SH Bush","year":"2014","unstructured":"Bush SH, Grassau PA, Yarmo MN, Zhang T, Zinkie SJ, Pereira JL. The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice. BMC Palliative Care. 2014;13:17.","journal-title":"BMC Palliative Care."},{"key":"576_CR14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O\u2019Neal PV, Keane KA, et al. The Richmond Agitation Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338\u201344.","journal-title":"Am J Respir Crit Care Med."},{"key":"576_CR15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jpainsymman.2011.11.010","volume":"44","author":"JJ Arevalo","year":"2012","unstructured":"Arevalo JJ, Brinkkemper T, van der Heide A, Rietjens JA, Ribbe M, Deliens L, et al. AMROSE Site Study Group. Palliative sedation: reliability and validity of sedation scales. J Pain Symptom Manage. 2012;44:704\u201314.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4037\/ajcc2006.15.4.420","volume":"15","author":"C G\u00e9linas","year":"2006","unstructured":"G\u00e9linas C, Fillion L, Puntillo KA, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care. 2006;15:420\u20137.","journal-title":"Am J Crit Care."},{"key":"576_CR17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2044.1991.tb09345.x","volume":"46","author":"GE Rudkin","year":"1991","unstructured":"Rudkin GE, Osborne GA, Curtis NJ. Intra-opertaivepatient-controlledsedation. Anesthesia. 1991;46:90\u20132.","journal-title":"Anesthesia."},{"key":"576_CR18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpainsymman.2016.01.011","volume":"52","author":"AD Masman","year":"2016","unstructured":"Masman AD, van Dijk M, van Rosmalen J, van Oud-Alblas HJ, Ista E, Baar FP, Tibboel D. Bispectral index monitoring in terminally ill patients: a validation study. J Pain Symptom Manage. 2016;52:212\u201320.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpainsymman.2016.12.335","volume":"54","author":"M Barbato","year":"2017","unstructured":"Barbato M, Barclay G, Potter J, Yeo W, Chung J. Correlation between observational scales of sedation and comfort and Bispectral Index Scores (BIS). J Pain Symptom Manage. 2017;54:186\u201393.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jpainsymman.2014.08.013","volume":"49","author":"EK Schildmann","year":"2015","unstructured":"Schildmann EK, Schildmann J, Kiesewetter I. Medication and monitoring in palliative sedation therapy: a systematic review and quality assessment of published guidelines. J Pain Symptom Manage. 2015;49:734\u201346.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/annonc\/mdp048","volume":"20","author":"M Maltoni","year":"2009","unstructured":"Maltoni M, Pittureri C, Scarpi E, Piccinini L, Martini F, Turci P, et al. Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol. 2009;20:1163\u20139.","journal-title":"Ann Oncol."},{"key":"576_CR22","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00520-012-1407-x","volume":"20","author":"M Maltoni","year":"2012","unstructured":"Maltoni M, Miccinesi G, Morino P, Scarpi E, Bulli F, Martini F, et al. Prospective observational italian study on palliative sedation in two hospice settings: differences in casemixes and clinical care. Support Care Cancer. 2012;20:2829\u201336.","journal-title":"Support Care Cancer."},{"key":"576_CR23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00520-011-1217-6","volume":"20","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Zecca E, Martini C, Gorni G, Campa T, Brunelli C, et al. Palliative sedation at the end of life at a tertiary cancer center. Support Care Cancer. 2012;20:1299\u2013307.","journal-title":"Support Care Cancer."},{"key":"576_CR24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jpainsymman.2011.06.027","volume":"43","author":"S Mercadante","year":"2012","unstructured":"Mercadante S, Porzio G, Valle A, Fusco F, Aielli F, Adile C, et al. Home Care-Italy Group (HOCAI)Palliative sedation in advanced cancer patients followed at home: a retrospective analysis. J Pain Symptom Manage. 2012;43:1126\u201330.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1049909111413890","volume":"29","author":"P Claessens","year":"2012","unstructured":"Claessens P, Menten J, Schotsmans P, Broeckaert B. Level of consciousnessin dying patients. The role of palliative sedation: a longitudinal prospectivestudy. Am J HospPalliat Care. 2012;29:195\u2013200.","journal-title":"Am J HospPalliat Care"},{"key":"576_CR26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archinternmed.2009.542","volume":"170","author":"K Chambaere","year":"2010","unstructured":"Chambaere K, Bilsen J, Cohen J, Rietjens JA, Onwuteaka-Philipsen BD, Mortier F, et al. Continuous deep sedation until death in Belgium: a nationwide survey. Arch Intern Med. 2010;170:490\u20133.","journal-title":"Arch Intern Med."},{"key":"576_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/082585979401000207","volume":"10","author":"NI Cherny","year":"1994","unstructured":"Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care. 1994;10:31\u20138.","journal-title":"J Palliat Care."},{"key":"576_CR28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s40265-017-0804-3","volume":"77","author":"SH Bush","year":"2017","unstructured":"Bush SH, Tierney S, Lawlor PG. Clinical assessment and management of delirium in the palliative care setting. Drugs. 2017;77:1623\u201343.","journal-title":"Drugs."},{"key":"576_CR29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1089\/jpm.2017.0265","volume":"21","author":"ML Campbell","year":"2018","unstructured":"Campbell ML, Kiernan JM, Strandmark J, Yarandi HN. trajectory of dyspnea and respiratory distress among patients in the last month of life. J Palliat Med. 2018;21:194\u20139.","journal-title":"J Palliat Med."},{"key":"576_CR30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jpainsymman.2018.01.013","volume":"55","author":"P Rodrigues","year":"2018","unstructured":"Rodrigues P, Crokaert J, Gastmans C. Palliative sedation for existential suffering: a systematic review of argument-based ethics literature. J Pain Symptom Manage. 2018;55:1577\u201390.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/07481187.2017.1386734","volume":"42","author":"AL Scherrens","year":"2018","unstructured":"Scherrens AL, Roelands M, Van den Block L, Deforche B, Deliens L, Cohen J. What influences intentions to request physician-assisted euthanasia or continuous deep sedation? Death Stud. 2018;42:491\u20137.","journal-title":"Death Stud."},{"key":"576_CR32","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1111\/j.1365-2648.2011.05711.x","volume":"67","author":"A Bruce","year":"2011","unstructured":"Bruce A, Boston P. Relieving existential suffering through palliative sedation: discussion of an uneasy practice. J Adv Nurs. 2011;67:2732\u201340.","journal-title":"J Adv Nurs."},{"key":"576_CR33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10673220802576917","volume":"16","author":"Z Schuman-Olivier","year":"2008","unstructured":"Schuman-Olivier Z, Brendel DH, Forstein M, Price BH. The use of palliative sedation for existential distress: a psychiatric perspective. Harv Rev Psychiatry. 2008;16:339\u201351.","journal-title":"Harv Rev Psychiatry."},{"key":"576_CR34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jpainsymman.2009.04.027","volume":"38","author":"DG Harris","year":"2009","unstructured":"Harris DG, Noble SI. Management of terminal hemorrhage in patients with advanced cancer: a systematic literature review. J Pain Symptom Manage. 2009;38:913\u201327.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/1049909111434472","volume":"29","author":"F Gon\u00e7alves","year":"2012","unstructured":"Gon\u00e7alves F, Almeida A, Teixeira S, Pereira S, Edra N. A protocol for the acute control of agitation in palliative care: a preliminary report. Am J Hosp Palliat Care. 2012;29:522\u20134.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpainsymman.2016.08.012","volume":"53","author":"T Morita","year":"2017","unstructured":"Morita T, Imai K, Yokomichi N, Mori M, Kizawa Y, Tsuneto S. Continuous deep sedation: a proposal for performing more rigorous empirical research. J Pain Symptom Manage. 2017;53:146\u201352.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00520-017-4011-2","volume":"26","author":"K Imai","year":"2018","unstructured":"Imai K, Morita T, Yokomichi N, Mori M, Naito AS, Tsukuura H, et al. Efficacy of two types of palliative sedation therapy defined using intervention protocols: proportional vs. deep sedation. Support Care Cancer. 2018;26:1763\u201371.","journal-title":"Support Care Cancer."},{"key":"576_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12904-018-0288-2","volume":"17","author":"K Laryionava","year":"2018","unstructured":"Laryionava K, Pfeil TA, Dietrich M, Reiter-Theil S, Hiddemann W, Winkler EC. The second patient? Family members of cancer patients and their role in end-of-life decision making. BMC Palliat Care. 2018;17:29.","journal-title":"BMC Palliat Care."},{"key":"576_CR39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/jpm.2016.0464","volume":"20","author":"S Maiser","year":"2017","unstructured":"Maiser S, Estrada-Stephen K, Sahr N, Gully J, Marks S. A survey of hospice and palliative care clinicians\u2019 experiences and attitudes regarding the use of palliative sedation. J Palliat Med. 2017;20:915\u201321.","journal-title":"J Palliat Med."},{"key":"576_CR40","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00520-017-3581-3","volume":"25","author":"S Mercadante","year":"2017","unstructured":"Mercadante S, Masedu F, Mercadante A, Marinangeli F, Aielli F. Attitudes of palliative home care physicians towards palliative sedation at home in Italy. Support Care Cancer. 2017;25:1615\u201320.","journal-title":"Support Care Cancer."},{"key":"576_CR41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jpainsymman.2010.07.013","volume":"41","author":"S Mercadante","year":"2011","unstructured":"Mercadante S, Porzio G, Valle A, Fusco F, Aielli F, Costanzo V. Home Care Italy Group Palliative sedation in patients with advanced cancer followed at home: a systematic review. J Pain Symptom Manage. 2011;41:754\u201360.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jpainsymman.2013.06.019","volume":"47","author":"S Mercadante","year":"2014","unstructured":"Mercadante S, Porzio G, Valle A, Aielli F, Casuccio A. Home Care-Italy Group Palliative sedation in patients with advanced cancer followed at home: a prospective study. J Pain Symptom Manage. 2014;47:860\u20136.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/17843286.2017.1331783","volume":"73","author":"P Pype","year":"2018","unstructured":"Pype P, Teuwen I, Mertens F, Sercu M, De Sutter A. Suboptimal palliative sedation in primary care: an exploration. Acta Clin Belg. 2018;73:21\u20138.","journal-title":"Acta Clin Belg."},{"key":"576_CR44","first-page":"30133","volume":"13","author":"A Caraceni","year":"2018","unstructured":"Caraceni A, Speranza R, Spoldi E, Ambroset CS, Canestrari S, Marinari M, et al. Italian Society of Palliative Care Study Group on Palliative Sedation. Palliative sedation in terminal cancer patients admitted to hospice or home care programs: does the setting matter? Results from a national multicenter observational study in adult cancer patients. J Pain Symptom Manage. 2018;13:30133\u20137.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/jpm.2017.0179","volume":"21","author":"JJ Arevalo","year":"2018","unstructured":"Arevalo JJ, Geijteman ECT, Huisman BAA, Dees MK, Zuurmond WWA, van Zuylen L, et al. Medication use in the last days of life in hospital, hospice, and home settings in the Netherlands. J Palliat Med. 2018;21:149\u201355.","journal-title":"J Palliat Med."},{"key":"576_CR46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S1478951516000948","volume":"15","author":"J Smedb\u00e4ck","year":"2017","unstructured":"Smedb\u00e4ck J, \u00d6hl\u00e9n J, \u00c5restedt K, Alvariza A, F\u00fcrst CJ, H\u00e5kanson C. Palliative care during the final week of life of older people in nursing homes: a register-based study. Palliat Support Care. 2017;15:417\u201324.","journal-title":"Palliat Support Care."},{"key":"576_CR47","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jpainsymman.2017.12.489","volume":"55","author":"S Andersson","year":"2018","unstructured":"Andersson S, \u00c5restedt K, Lindqvist O, F\u00fcrst CJ, Br\u00e4nnstr\u00f6m M. Factors associated with symptom relief in end-of-life care in residential care homes: a national register-based study. J Pain Symptom Manage. 2018;55:1304\u201312.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jpainsymman.2016.12.353","volume":"53","author":"Y Eun","year":"2017","unstructured":"Eun Y, Hong IW, Bruera E, Kang JH. Qualitative study on the perceptions of terminally ill cancer patients and their family members regarding end-of-life experiences focusing on palliative sedation. J Pain Symptom Manage. 2017;53:1010\u20136.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR49","first-page":"pii E36","volume":"7","author":"AR Trees","year":"2017","unstructured":"Trees AR, Ohs JE, Murray MC. Family communication about end-of-life decisions and the enactment of the decision maker role. BehavSci (Basel). 2017;7:pii E36.","journal-title":"BehavSci (Basel)."},{"key":"576_CR50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/jpm.2017.0029","volume":"21","author":"M L\u00f6vgren","year":"2018","unstructured":"L\u00f6vgren M, Sveen J, Nyberg T, Eileg\u00e5rdWallin A, Prigerson HG, Steineck G, et al. Care at end of life influences grief: a nationwide long-term follow-up among young adults who lost a brother or sister to childhood cancer. J Palliat Med. 2018;21:156\u201362.","journal-title":"J Palliat Med."},{"key":"576_CR51","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jpainsymman.2018.02.007","volume":"55","author":"HS Shen","year":"2018","unstructured":"Shen HS, Chen SY, Cheung DST, Wang SY, Jung Jae L, Lin CC. Differential family experience of palliative sedation therapy in specialised palliative or critical careunits. J Pain Symptom Manage. 2018;55:1531\u20139.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0269216316647207","volume":"31","author":"A Giles","year":"2017","unstructured":"Giles A, Sykes N. To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: a retrospective case note review: does midazolam affect oral intake in the dying? Palliat Med. 2017;31:89\u201392.","journal-title":"Palliat Med."},{"key":"576_CR53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/SPC.0b013e328356ab4a","volume":"6","author":"R Dev","year":"2012","unstructured":"Dev R, Dalal S, Bruera E. Is there a role for parenteral nutrition or hydration at the end of life? Curr Opin Support Palliat Care. 2012;6:365\u201370.","journal-title":"Curr Opin Support Palliat Care."},{"key":"576_CR54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/17425255.2016.1179281","volume":"12","author":"LG Franken","year":"2016","unstructured":"Franken LG, de Winter BC, van Esch HJ, van Zuylen L, Baar FP, Tibboel D, et al. Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol. 2016;12:669\u201380.","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"576_CR55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40262-015-0345-4","volume":"55","author":"LG Franken","year":"2016","unstructured":"Franken LG, Masman AD, de Winter BC, Koch BC, Baar FP, Tibboel D, et al. Pharmacokinetics of morphine, morphine-3-glucuronide and morphine-6-glucuronide in terminally ill adult patients. Clin Pharmacokinet. 2016;55:697\u2013709.","journal-title":"Clin Pharmacokinet."},{"key":"576_CR56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bcp.13442","volume":"84","author":"LG Franken","year":"2018","unstructured":"Franken LG, de Winter BCM, Masman AD, van Dijk M, Baar FPM, Tibboel D, et al. Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patients. Br J Clin Pharmacol. 2018;84:320\u201330.","journal-title":"Br J Clin Pharmacol."},{"key":"576_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12904-017-0195-y","volume":"16","author":"A Dickman","year":"2017","unstructured":"Dickman A, Bickerstaff M, Jackson R, Schneider J, Mason S, Ellershaw J. Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability. BMC Palliat Care. 2017;16:22.","journal-title":"BMC Palliat Care."},{"key":"576_CR58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpainsymman.2005.03.017","volume":"30","author":"T Morita","year":"2005","unstructured":"Morita T, Chinone Y, Ikenaga M, et al. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage. 2005;30:320\u20138.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR59","first-page":"375","volume-title":"Psychopharmacology in oncology and palliative care","author":"L Ferrari","year":"2014","unstructured":"Ferrari L, Caraceni A. Pharmacology of sedation. In: Grassi L, Riba M, editors. Psychopharmacology in oncology and palliative care. Berlin: Springer-Verlag; 2014. p. 375."},{"key":"576_CR60","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/bcp.13259","volume":"83","author":"LG Franken","year":"2017","unstructured":"Franken LG, Masman AD, de Winter BC, Baar FP, Tibboel D, van Gelder T, et al. Hypoalbuminemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect? Br J Clin Pharmacol. 2017;83:1701\u201312.","journal-title":"Br J Clin Pharmacol."},{"key":"576_CR61","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0885-3924(01)00412-2","volume":"23","author":"C Cheng","year":"2002","unstructured":"Cheng C, Roemer-Becuwe C, Pereira J. When midazolam fails. J Symptom Manage. 2002;23:256\u201365.","journal-title":"J Symptom Manage."},{"key":"576_CR62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15360288.2017.1279502","volume":"31","author":"J Bodnar","year":"2017","unstructured":"Bodnar J. A review of agents for palliative sedation\/continuous deep sedation: pharmacology and practical applications. J Pain Palliat Care Pharmacother. 2017;31:16\u201337.","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"576_CR63","first-page":"CD010206","volume":"1","author":"EM Beller","year":"2015","unstructured":"Beller EM, van Driel ML, McGregor L, Truong S, Mitchell G. Palliative pharmacological sedation for terminally ill adults. Cochrane Database Syst Rev. 2015;1:CD010206.","journal-title":"Cochrane Database Syst Rev."},{"key":"576_CR64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.2017.11468","volume":"318","author":"D Hui","year":"2017","unstructured":"Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, et al. Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial. JAMA. 2017;318:1047\u201356.","journal-title":"JAMA."},{"key":"576_CR65","volume-title":"Oxford textbook of palliative medicine","year":"1993","unstructured":"Doyle D, Hanks GWC, MacDonald N, editors. Oxford textbook of palliative medicine. 1st ed. Oxford: Oxford University Press; 1993.","edition":"1"},{"key":"576_CR66","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00228-017-2283-6","volume":"73","author":"LG Franken","year":"2017","unstructured":"Franken LG, Mathot RAA, Masman AD, Baar FPM, Tibboel D, van Gelder T, et al. Population pharmacokinetics of haloperidol in terminally ill adult patients. Eur J Clin Pharmacol. 2017;73:1271\u20137.","journal-title":"Eur J Clin Pharmacol."},{"key":"576_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","volume":"177","author":"MR Agar","year":"2017","unstructured":"Agar MR, Lawlor PG, Quinn S, Draper B, Caplan GA, Rowett D, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017;177:34\u201342.","journal-title":"JAMA Intern Med."},{"key":"576_CR68","doi-asserted-by":"crossref","first-page":"JC32","DOI":"10.7326\/ACPJC-2017-166-6-032","volume":"166","author":"J Lee","year":"2017","unstructured":"Lee J, Holbrook A. In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo. Ann Intern Med. 2017;166:JC32.","journal-title":"Ann Intern Med."},{"key":"576_CR69","first-page":"396B","volume":"95","author":"Kulkarni N Shrikant","year":"2017","unstructured":"Shrikant Kulkarni N. Antipsychotics worsen symptoms in patients with delirium who receive palliative care. Am Fam Physician. 2017;95:396B.","journal-title":"Am Fam Physician."},{"key":"576_CR70","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/ebmed-2017-110723","volume":"22","author":"S Boettger","year":"2017","unstructured":"Boettger S, Jenewein J. Placebo might be superior to antipsychotics in management of delirium in the palliative care setting. Evid Based Med. 2017;22:152\u20133.","journal-title":"Evid Based Med."},{"key":"576_CR71","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/1049909117753828","volume":"35","author":"B Kayhart","year":"2018","unstructured":"Kayhart B, Lapid MI, Nelson S, Cunningham JL, Thompson VH, Leung JG. A lack of systemic absorption following the repeated application of topical quetiapine in healthy adults. Am J HospPalliat Care. 2018;35:1076\u201380.","journal-title":"Am J HospPalliat Care."},{"key":"576_CR72","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00520-016-3371-3","volume":"25","author":"D Walsh","year":"2017","unstructured":"Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A. 2016 Updated MASCC\/ESMO consensus recommendations: management of nausea and vomiting in advanced cancer. Support Care Cancer. 2017;25:333\u201340.","journal-title":"Support Care Cancer."},{"key":"576_CR73","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jpainsymman.2010.02.017","volume":"40","author":"A Elsayem","year":"2010","unstructured":"Elsayem A, Bush SH, Munsell MF, Curry E 3rd, Calderon BB, Paraskevopoulos T, et al. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study. J Pain Symptom Manage. 2010;40:774\u201382.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR74","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/13543784.12.4.655","volume":"12","author":"PE Keck Jr","year":"2003","unstructured":"Keck PE Jr, McElroy SL. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic. Expert Opin Investig Drugs. 2003;12:655\u201362.","journal-title":"Expert Opin Investig Drugs."},{"key":"576_CR75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1049909115612800","volume":"34","author":"E Prommer","year":"2017","unstructured":"Prommer E. Aripiprazole. Am J Hosp Palliat Care. 2017;34:180\u20135.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/psyg.12088","volume":"15","author":"E Kirino","year":"2015","unstructured":"Kirino E. Use of aripiprazole for delirium in the elderly: a short review. Psychogeriatrics. 2015;15:75\u201384.","journal-title":"Psychogeriatrics."},{"key":"576_CR77","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/SPC.0000000000000236","volume":"10","author":"D Hui","year":"2016","unstructured":"Hui D, Dev R, Bruera E. Neuroleptics in the management of delirium in patients with advanced cancer. Curr Opin Support Palliat Care. 2016;10:316\u201323.","journal-title":"Curr Opin Support Palliat Care."},{"key":"576_CR78","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/1049909113507124","volume":"31","author":"PB Bascom","year":"2014","unstructured":"Bascom PB, Bordley JL, Lawton AJ. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life. Am J Hosp Palliat Care. 2014;31:808\u201311.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR79","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/1049909116668160","volume":"34","author":"A Chen","year":"2017","unstructured":"Chen A, Loquias EJ, Roshan R, Levene R, Zelhof R, Hickey T, et al. Safe use of subcutaneous diphenhydramine in the Inpatient Hospice Unit. Am J Hosp Palliat Care. 2017;34:954\u20137.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/1049909110389804","volume":"28","author":"E Prommer","year":"2011","unstructured":"Prommer E. Dexmedetomidine: does it have potential in palliative medicine? Am J Hosp Palliat Care. 2011;28:276\u201383.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR81","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1089\/jpm.2016.0419","volume":"20","author":"J Burns","year":"2017","unstructured":"Burns J, Jackson K, Sheehy KA, Finkel JC, Quezado ZM. The use of dexmedetomidine in pediatric palliative care: a preliminary study. J Palliat Med. 2017;20:779\u201383.","journal-title":"J Palliat Med."},{"key":"576_CR82","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/jpm.2016.0184","volume":"20","author":"JF Ciais","year":"2017","unstructured":"Ciais JF, Tremellat F, Castelli-Prieto M, Jestin C. Sedation by propofol for painful care procedures at the end of life: a pilot study. PROPOPAL 1. J Palliat Med. 2017;20:282\u20134.","journal-title":"J Palliat Med."},{"key":"576_CR83","first-page":"1","volume":"16","author":"A Covarrubias-G\u00f3mez","year":"2017","unstructured":"Covarrubias-G\u00f3mez A, L\u00f3pezCollada-Estrada M. Propofol-based palliative sedation to treat antipsychotic-resistant agitated delirium. J Pain Palliat Care Pharmacother. 2017;16:1\u20135.","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"576_CR84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmjspcare-2016-001261","volume":"8","author":"AE Sutherland","year":"2018","unstructured":"Sutherland AE, Curtin J, Bradley V, Bush O, Presswood M, Hedges V, et al. Subcutaneous levetiracetam for the management of seizures at the end of life. BMJ Support Palliat Care. 2018;8:129\u201335.","journal-title":"BMJ Support Palliat Care."},{"key":"576_CR85","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2008.05.002","volume":"36","author":"MJ Carter","year":"2008","unstructured":"Carter MJ, Gibbins J, Senior-Smith G, Thomas S, Guest P, Forbes K. Ketamine: does it have a role in palliative sedation? J Pain Symptom Manage. 2008;36:e1\u20133.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(15)00401-5","volume":"17","author":"I Maeda","year":"2016","unstructured":"Maeda I, Morita T, Yamaguchi T, Inoue S, Ikenaga M, Matsumoto Y, et al. Effect of continuous deep sedation on survival in patients with advanced cancer (J-Proval): a propensity score-weighted analysis of a prospective cohort study. Lancet Oncol. 2016;17:115\u201322.","journal-title":"Lancet Oncol."},{"key":"576_CR87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpainsymman.2017.08.004","volume":"55","author":"M Gol\u010di\u0107","year":"2018","unstructured":"Gol\u010di\u0107 M, Dobrila-Dintinjana R, Gol\u010di\u0107 G, \u010cubrani\u0107 A. The impact of combined use of opioids, antipsychotics and anxiolytics on survival in the hospice setting. J Pain Symptom Manage. 2018;55:22\u201330.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR88","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1089\/jpm.2017.0364","volume":"20","author":"L Lima De","year":"2017","unstructured":"De Lima L, Wenk R, Pettus K, Radbruch L. No occultation in the international association for hospice and palliative care position statement on palliative care and assisted suicide. J Palliat Med. 2017;20:1309\u201310.","journal-title":"J Palliat Med."},{"key":"576_CR89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269216315616524","volume":"30","author":"L Radbruch","year":"2016","unstructured":"Radbruch L, Leget C, Bahr P, M\u00fcller-Busch C, Ellershaw J, de Conno F, et al. Board members of EAPC. Euthanasia and physician-assisted suicide: a white paper from the European Association for Palliative Care. Palliat Med. 2016;30:104\u201316.","journal-title":"Palliat Med."},{"key":"576_CR90","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/CCM.0000000000002260","volume":"45","author":"G Koff","year":"2017","unstructured":"Koff G, Vaid U, Len E, Crawford A, Oxman DA. Differences in utilization of life support and end-of-life care for medical icu patients with versus without cancer. Crit Care Med. 2017;45:e379\u201383.","journal-title":"Crit Care Med."},{"key":"576_CR91","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/1049909116649986","volume":"34","author":"D Leung","year":"2017","unstructured":"Leung D, Angus JE, Sinuff T, Bavly S, Rose L. Transitions to end-of-life care for patients with chronic critical illness: a meta-synthesis. Am J Hosp Palliat Care. 2017;34:729\u201336.","journal-title":"Am J Hosp Palliat Care."},{"key":"576_CR92","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpainsymman.2017.09.015","volume":"55","author":"L Axelsson","year":"2018","unstructured":"Axelsson L, Alvariza A, Lindberg J, \u00d6hl\u00e9n J, H\u00e5kanson C, Reimertz H, et al. Unmet palliative care needs among patients with end-stage kidney disease: a national registry study about the last week of life. J Pain Symptom Manage. 2018;55:236\u201344.","journal-title":"J Pain Symptom Manage."},{"key":"576_CR93","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jpm.2017.0125","volume":"21","author":"K \u00c5restedt","year":"2018","unstructured":"\u00c5restedt K, Alvariza A, Boman K, \u00d6hl\u00e9n J, Goliath I, H\u00e5kanson C, et al. Symptom relief and palliative care during the last week of life among patients with heart failure: a national register study. J Palliat Med. 2018;21:361\u20137.","journal-title":"J Palliat Med."},{"key":"576_CR94","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/13607863.2017.1286459","volume":"22","author":"YS Bergman","year":"2018","unstructured":"Bergman YS, Bodner E, Shrira A. Subjective nearness to death and end-of-life anxieties: the moderating role of ageism. Aging Ment Health. 2018;22:678\u201385.","journal-title":"Aging Ment Health."},{"key":"576_CR95","doi-asserted-by":"crossref","first-page":"e20170487","DOI":"10.1542\/peds.2017-0487","volume":"140","author":"LM Johnson","year":"2017","unstructured":"Johnson LM, Frader J, Wolfe J, Baker JN, Anghelescu DL, et al. Palliative sedation with propofol for an adolescent with a DNR order. Pediatrics. 2017;140:e20170487.","journal-title":"Pediatrics."},{"key":"576_CR96","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.pcl.2017.06.012","volume":"64","author":"ML Suttle","year":"2017","unstructured":"Suttle ML, Jenkins TL, Tamburro RF. End-of-Life and bereavement care in pediatric intensive care units. Pediatr Clin North Am. 2017;64:1167\u201383.","journal-title":"Pediatr Clin North Am."},{"key":"576_CR97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12904-017-0205-0","volume":"16","author":"S Ziegler","year":"2017","unstructured":"Ziegler S, Merker H, Schmid M, Puhan MA. The impact of the inpatient practice of continuous deep sedation until death on healthcare professionals emotional well being: a systematic review. BMC Palliat Care. 2017;16:30.","journal-title":"BMC Palliat Care."},{"key":"576_CR98","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/0269216318764095","volume":"32","author":"E Schildmann","year":"2018","unstructured":"Schildmann E, P\u00f6rnbacher S, Kalies H, Bausewein C. Palliative sedation? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit. Palliat Med. 2018;32:1189\u201397.","journal-title":"Palliat Med."},{"key":"576_CR99","doi-asserted-by":"crossref","unstructured":"Rietjens JA, van Delden JJ, van der Heide A. Palliative sedation: the end of heated debate? Palliat Med. 2018;269216318762708. (Epub ahead of print).","DOI":"10.1177\/0269216318762708"},{"key":"576_CR100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2016.06.007","volume":"65","author":"M Maltoni","year":"2016","unstructured":"Maltoni M, Scarpi E, Dall\u2019Agata M, Zagonel V, Bert\u00e8 R, Ferrari D, et al. Early Palliative Care Italian Study Group (EPCISG). Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. Eur J Cancer. 2016;65:61\u20138.","journal-title":"Eur J Cancer."},{"key":"576_CR101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejca.2016.10.004","volume":"69","author":"M Maltoni","year":"2016","unstructured":"Maltoni M, Scarpi E, Dall\u2019Agata M, Schiavon S, Biasini C, Codec\u00e0 C, et al. Early Palliative Care Italian Study Group (EPCISG). Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer. 2016;69:110\u20138.","journal-title":"Eur J Cancer."},{"key":"576_CR102","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2017.75.6676","volume":"36","author":"M Hoerger","year":"2018","unstructured":"Hoerger M, Greer JA, Jackson VA, Park ER, Pirl WF, El-Jawahri A, et al. Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. J ClinOncol. 2018;36:1096\u2013102.","journal-title":"J ClinOncol."},{"key":"576_CR103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmjspcare-2017-001477","volume":"8","author":"EA Davies","year":"2018","unstructured":"Davies EA. Why we need more poetry in palliative care. BMJ Support Palliat Care. 2018;8:266\u201370.","journal-title":"BMJ Support Palliat Care."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0576-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0576-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0576-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T20:32:30Z","timestamp":1720643550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0576-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0576-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"27 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used in the preparation of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ferdinando Garetto, Ferdinando Cancelli, Romina Rossi and Marco Maltoni have no conflicts of interest to declare for this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Given the nature of this paper, ethical approval and informed consent were not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}